Below are the top drug delivery stocks on the NYSE
in terms of revenue.
The trailing-twelve-month revenue at Hospira (NYSE: HSP) is $4.02 billion. Hospira had $655.90 million in total cash for the latest quarter.
The trailing-twelve-month revenue at Valeant Pharmaceuticals International (NYSE: VRX) is $2.75 billion. Valeant Pharmaceuticals' operating margin for the same period is 23.99%.
The trailing-twelve-month revenue at Elan Corporation plc (NYSE: ELN) is $1.29 billion. Elan's ROE for the same period is 102.84%.
The trailing-twelve-month revenue at K-V Pharmaceutical Company (NYSE: KV-A) is $23.20 million. K-V Pharmaceutical had $50.70 million in total cash for the latest quarter.
Connect with Benzinga on LinkedIn - join the discussion today.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Tags: Drug Delivery Industry, Highest Revenue, NYSE
Posted in: Trading Ideas
